|
RALB expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.1405099914773E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.55111512312578E-16 |
| Normal-vs-Stage2 |
1.800960E-03 |
| Normal-vs-Stage3 |
1.257400E-03 |
| Normal-vs-Stage4 |
6.120100E-02 |
| Stage1-vs-Stage2 |
3.557800E-01 |
| Stage1-vs-Stage3 |
8.258400E-03 |
| Stage1-vs-Stage4 |
2.988600E-04 |
| Stage2-vs-Stage3 |
3.674800E-01 |
| Stage2-vs-Stage4 |
8.786200E-02 |
| Stage3-vs-Stage4 |
2.937800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63546953757532E-12 |
| Normal-vs-AfricanAmerican |
5.942800E-01 |
| Normal-vs-Asian |
9.217600E-02 |
| Caucasian-vs-AfricanAmerican |
1.362510E-03 |
| Caucasian-vs-Asian |
7.961000E-01 |
| AfricanAmerican-vs-Asian |
2.865000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.54720000436981E-09 |
| Normal-vs-Female |
2.12909689878416E-11 |
| Male-vs-Female |
1.315510E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.813420E-01 |
| Normal-vs-Age(41-60Yrs) |
1.02929997858325E-10 |
| Normal-vs-Age(61-80Yrs) |
2.96019997403363E-09 |
| Normal-vs-Age(81-100Yrs) |
7.634200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.682200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.048600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.043200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.814800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.900200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.947000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.501000E-03 |
| Normal-vs-Grade 2 |
1.62636570877339E-12 |
| Normal-vs-Grade 3 |
2.88590000008249E-07 |
| Normal-vs-Grade 4 |
5.167200E-01 |
| Grade 1-vs-Grade 2 |
3.226400E-01 |
| Grade 1-vs-Grade 3 |
4.356500E-02 |
| Grade 1-vs-Grade 4 |
4.617500E-04 |
| Grade 2-vs-Grade 3 |
6.618500E-03 |
| Grade 2-vs-Grade 4 |
2.43819999967698E-07 |
| Grade 3-vs-Grade 4 |
5.776100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
2.561800E-01 |
| ccA subtype-vs-ccB subtype |
1.11022302462516E-16 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.94079999135977E-10 |
| Normal-vs-N1 |
5.668400E-01 |
| N0-vs-N1 |
1.917220E-01 |
|
|
